Spero Therapeutics, Inc. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
Spero Therapeutics, Inc. (SPRO) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2022-05-16
- 2022-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-04 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 10-Q · filed 2017-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |